){kind=logo}
Loeb & Loeb LLP is proud to sponsor the 7th Annual Summit on Life Sciences IP Due Diligence Conference taking place from December 4-5, 2024, where Co-Chair, Life Sciences, Kathleen Gersh will be speaking on the panel “Ownership and Inventorship: Who Holds the Rights” on December 5.
From the event website:
A strong intellectual property portfolio is one of the most important assets for a life sciences company. Over the last year, a perfect legal and regulatory storm has been unleashed on the life sciences industry and is greatly impacting IP Due Diligence. ACI’s 7th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with the tools and critical information you need to develop winning strategies and ensure strong, valuable, and protected IP Assets that can hold up under pressure. Our esteemed speakers will provide insights on what to look for during the due diligence process, how to strategize in a shifting landscape, and how to avoid potential patent pitfalls.
For more information, including how to register, please visit the event website.
From the event website:
A strong intellectual property portfolio is one of the most important assets for a life sciences company. Over the last year, a perfect legal and regulatory storm has been unleashed on the life sciences industry and is greatly impacting IP Due Diligence. ACI’s 7th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with the tools and critical information you need to develop winning strategies and ensure strong, valuable, and protected IP Assets that can hold up under pressure. Our esteemed speakers will provide insights on what to look for during the due diligence process, how to strategize in a shifting landscape, and how to avoid potential patent pitfalls.
For more information, including how to register, please visit the event website.
